These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 36607615)
1. Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma. Yu Z; Lv Y; Su C; Lu W; Zhang R; Li J; Guo B; Yan H; Liu D; Yang Z; Mi H; Mo L; Guo Y; Feng W; Xu H; Peng W; Cheng J; Nan A; Mo Z Cancer Res; 2023 Mar; 83(5):700-719. PubMed ID: 36607615 [TBL] [Abstract][Full Text] [Related]
2. Unfolding the mysteries of heterogeneity from a high-resolution perspective: integration analysis of single-cell multi-omics and spatial omics revealed functionally heterogeneous cancer cells in ccRCC. Zheng J; Lu W; Wang C; Chen S; Zhang Q; Su C Aging (Albany NY); 2024 Jun; 16(13):10943-10971. PubMed ID: 38944814 [TBL] [Abstract][Full Text] [Related]
3. Characterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencing. Malouf GG; Zhang J; Yuan Y; Compérat E; Rouprêt M; Cussenot O; Chen Y; Thompson EJ; Tannir NM; Weinstein JN; Valero V; Khayat D; Spano JP; Su X Mol Oncol; 2015 Jan; 9(1):32-43. PubMed ID: 25126716 [TBL] [Abstract][Full Text] [Related]
4. Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma. Gong Q; Jiang Y; Xiong J; Liu F; Guan J Front Immunol; 2023; 14():1199002. PubMed ID: 37503331 [TBL] [Abstract][Full Text] [Related]
5. Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma. Long Z; Sun C; Tang M; Wang Y; Ma J; Yu J; Wei J; Ma J; Wang B; Xie Q; Wen J Cell Discov; 2022 Jul; 8(1):68. PubMed ID: 35853872 [TBL] [Abstract][Full Text] [Related]
6. The integrate profiling of single-cell and spatial transcriptome RNA-seq reveals tumor heterogeneity, therapeutic targets, and prognostic subtypes in ccRCC. Zhang Y; Huang X; Yu M; Zhang M; Zhao L; Yan Y; Zhang L; Wang X Cancer Gene Ther; 2024 Jun; 31(6):917-932. PubMed ID: 38480978 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis. Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910 [TBL] [Abstract][Full Text] [Related]
9. Integration of scATAC-Seq with scRNA-Seq Data. Berest I; Tangherloni A Methods Mol Biol; 2023; 2584():293-310. PubMed ID: 36495457 [TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma. Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920 [TBL] [Abstract][Full Text] [Related]
11. Dissecting LncRNA Roles in Renal Cell Carcinoma Metastasis and Characterizing Genomic Heterogeneity by Single-Cell RNA-seq. Li X; Meng X; Wei C; Zhou Y; Chen H; Huang H; Chen M Mol Cancer Res; 2018 Dec; 16(12):1879-1888. PubMed ID: 30082482 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of hydroxymethylglutaryl CoA synthase reduces ketogenesis and facilitates tumor cell motility in clear cell renal carcinoma. Han P; Wang Y; Luo W; Lu Y; Zhou X; Yang Y; Zheng Q; Li D; Wu S; Li L; Zhang H; Zhao J; Zhang Z; Matskova L; Li P; Zhou X Pathol Res Pract; 2021 Nov; 227():153622. PubMed ID: 34624592 [TBL] [Abstract][Full Text] [Related]
13. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma. Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749 [TBL] [Abstract][Full Text] [Related]
14. Transcriptional Profiling Reveals Kidney Neutrophil Heterogeneity in Both Healthy People and ccRCC Patients. Meng Y; Cai K; Zhao J; Huang K; Ma X; Song J; Liu Y J Immunol Res; 2021; 2021():5598627. PubMed ID: 33791390 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive profiling of circRNAs and the tumor suppressor function of circHIPK3 in clear cell renal carcinoma. Li H; Heng B; Ouyang P; Xie X; Zhang T; Chen G; Chen Z; Cheang K; Lai C J Mol Histol; 2020 Jun; 51(3):317-327. PubMed ID: 32409849 [TBL] [Abstract][Full Text] [Related]
17. m Chen Y; Zhou C; Sun Y; He X; Xue D Epigenomics; 2020 Jan; 12(2):87-99. PubMed ID: 31856595 [No Abstract] [Full Text] [Related]
18. Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma. Mehdi A; Riazalhosseini Y Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28812986 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation. Wang X; Cheng Y; Zhu Y; Li H; Ge W; Wu X; Zhao K; Yuan J; Li Z; Jiang S; Han Z; Jiang Q; Wu Q; Liu T; Zhang C; Yu M; Hu Y Int J Cancer; 2017 Oct; 141(7):1422-1433. PubMed ID: 28656647 [TBL] [Abstract][Full Text] [Related]
20. Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma. Ma W; Zhong M; Liu X Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34402862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]